UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 167

Sortiert nach

A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results

Trials, 2015-11, Vol.16 (485), p.495-495, Article 495

2015

Link zum Volltext

Verfügbarkeit prüfen

Propensity score matching and subclassification in observational studies with multi-level treatments

Biometrics, 2016-12, Vol.72 (4), p.1055-1065

2016

Link zum Volltext

Verfügbarkeit prüfen

The cost of relapse and the predictors of relapse in the treatment of schizophrenia

BMC psychiatry, 2010-01, Vol.10 (1), p.2-2, Article 2

2010

Link zum Volltext

Verfügbarkeit prüfen

Estimating optimal treatment regimes via subgroup identification in randomized control trials and observational studies

Statistics in medicine, 2016-08, Vol.35 (19), p.3285-3302

2016

Link zum Volltext

Verfügbarkeit prüfen

Practical recommendations on double score matching for estimating causal effects

Statistics in medicine, 2022-04, Vol.41 (8), p.1421-1445

2022

Link zum Volltext

Verfügbarkeit prüfen

Propensity score matching for estimating a marginal hazard ratio

Statistics in medicine, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

The burden of depressive symptoms in the long-term treatment of patients with schizophrenia

Schizophrenia research, 2007-02, Vol.90 (1), p.186-197

2007

Link zum Volltext

Verfügbarkeit prüfen

Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care

The journal of clinical psychiatry, 2006-03, Vol.67 (3), p.453

2006

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study

Headache, 2022-02, Vol.62 (2), p.122-140

2022

Link zum Volltext

Verfügbarkeit prüfen

Causal analyses with target trial emulation for real-world evidence removed large self-inflicted biases: systematic bias assessment of ovarian cancer treatment effectiveness

Journal of clinical epidemiology, 2022-12, Vol.152, p.269-280

2022

Link zum Volltext

Verfügbarkeit prüfen

Addressing unmeasured confounding in comparative observational research

Pharmacoepidemiology and drug safety, 2018-04, Vol.27 (4), p.373-382

2018

Link zum Volltext

Verfügbarkeit prüfen

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

BMC psychiatry, 2005-05, Vol.5 (1), p.26-26, Article 26

2005

Link zum Volltext

Verfügbarkeit prüfen

The Association Between Adherence to Insulin Therapy and Health Care Costs for Adults with Type 2 Diabetes: Evidence from a U.S. Retrospective Claims Database

Journal of managed care & specialty pharmacy, 2020-09, Vol.26 (9), p.1081

2020

Link zum Volltext

Verfügbarkeit prüfen

1027-P: Predicting Response to Bolus Insulin

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Link zum Volltext

Verfügbarkeit prüfen

Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment

Statistics in biopharmaceutical research, 2023-01, Vol.15 (1), p.3-13

2023

Link zum Volltext

Verfügbarkeit prüfen

Predicting Response to Bolus Insulin Therapy in Patients With Type 2 Diabetes

Journal of diabetes science and technology, 2023-11, Vol.17 (6), p.1573-1579

2023

Link zum Volltext

Verfügbarkeit prüfen

Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries

Alzheimer's & dementia, 2015-08, Vol.11 (8), p.887-895

2015

Link zum Volltext

Verfügbarkeit prüfen

Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine

Current medical research and opinion, 2018-04, Vol.34 (4), p.619-632

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluating different strategies for estimating treatment effects in observational studies

Journal of biopharmaceutical statistics, 2017-05, Vol.27 (3), p.535-553

2017

Link zum Volltext

Verfügbarkeit prüfen

Predicting optimal treatment regimens for patients with HR+/HER2- breast cancer using machine learning based on electronic health records

Journal of comparative effectiveness research, 2021-06, Vol.10 (9), p.777-795

2021

Link zum Volltext

Verfügbarkeit prüfen

Predictors of switching antipsychotic medications in the treatment of schizophrenia

BMC psychiatry, 2010-09, Vol.10 (1), p.75-75, Article 75

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia

Schizophrenia bulletin, 2008-11, Vol.34 (6), p.1163-1171

2008

Link zum Volltext

Verfügbarkeit prüfen

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia

BMC psychiatry, 2009-09, Vol.9 (1), p.54-54, Article 54

2009

Link zum Volltext

Verfügbarkeit prüfen

Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia

BMC psychiatry, 2010-01, Vol.10 (1), p.11-11, Article 11

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 167

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(143)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(121)
Life Sciences & Biomedicine
(120)
Humans
(104)
Female
(80)
Male
(77)
Adult
(53)
Psychiatry
(45)
Middle Aged
(44)
Treatment Outcome
(37)
Schizophrenia
(31)
Medical Sciences
(29)
Schizophrenia - Drug Therapy
(29)
Biological And Medical Sciences
(28)
Pharmacology & Pharmacy
(27)
Adolescent
(26)
Antipsychotic Agents - Therapeutic Use
(26)
United States
(25)
Psychology. Psychoanalysis. Psychiatry
(24)
Pharmacology. Drug Treatments
(22)
Double-Blind Method
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results

Propensity score matching and subclassification in observational studies with multi-level treatments

The cost of relapse and the predictors of relapse in the treatment of schizophrenia

Estimating optimal treatment regimes via subgroup identification in randomized control trials and observational studies

Practical recommendations on double score matching for estimating causal effects

Propensity score matching for estimating a marginal hazard ratio

The burden of depressive symptoms in the long-term treatment of patients with schizophrenia

Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care

Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study

Causal analyses with target trial emulation for real-world evidence removed large self-inflicted biases: systematic bias assessment of ovarian cancer treatment effectiveness

Addressing unmeasured confounding in comparative observational research

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

The Association Between Adherence to Insulin Therapy and Health Care Costs for Adults with Type 2 Diabetes: Evidence from a U.S. Retrospective Claims Database

1027-P: Predicting Response to Bolus Insulin

Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment

Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases

Predicting Response to Bolus Insulin Therapy in Patients With Type 2 Diabetes

Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries

Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine

Evaluating different strategies for estimating treatment effects in observational studies

Predicting optimal treatment regimens for patients with HR+/HER2- breast cancer using machine learning based on electronic health records

Predictors of switching antipsychotic medications in the treatment of schizophrenia

Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia

Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia

Suchergebnisse filtern